Search filters

List of works by Tijana Stanković

Association of CCND1 overexpression with KRAS and PTEN alterations in specific subtypes of non-small cell lung carcinoma and its influence on patients' outcome.

scientific article published on 9 June 2015

Chemo-protective and regenerative effects of diarylheptanoids from the bark of black alder (Alnus glutinosa) in human normal keratinocytes

scientific article published on 7 July 2015

Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples.

scientific article

Concurrent alteration of p16 and PTEN tumor suppressor genes could be considered as potential molecular marker for specific subgroups of NSCLC patients.

scientific article

Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin.

scientific article published on 27 May 2015

Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment.

scientific article

Genomic instability and p53 alterations in patients with malignant glioma.

scientific article published in June 2012

Identification of novel genetic alterations in samples of malignant glioma patients.

scientific article

Jatrophane diterpenoids with multidrug-resistance modulating activity from the latex of Euphorbia nicaeensis

scientific article published on 5 February 2018

Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives.

scientific article published on 22 July 2015

Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing

scientific article published on 10 August 2013

Mutual regulation and targeting of multidrug resistance and cancer stem phenotype

Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma.

scientific article published on 20 November 2014

Purine nucleoside analog--sulfinosine modulates diverse mechanisms of cancer progression in multi-drug resistant cancer cell lines

scientific article

Selective Anti-Cancer Drugs against Multi-drug Resistance

Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma.

scientific article published on 7 November 2016

Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma

scientific article